STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$26.90 USD
-0.12 (-0.44%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $26.87 -0.03 (-0.11%) 6:08 PM ET
4-Sell of 5 4
D Value C Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
STAAR Surgical Company's dividend yield currently sits at 0%, which is in-line with the Medical - Dental Supplies industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
STAA 26.90 -0.12(-0.44%)
Will STAA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STAA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STAA
Staar Surgical (STAA) Reports Q2 Loss, Beats Revenue Estimates
Henry Schein (HSIC) Q2 Earnings Lag Estimates
STAA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Staar Surgical (STAA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates
ProDex (PDEX) Moves 23.0% Higher: Will This Strength Last?
Other News for STAA
Staar Surgical price target raised to $28 from $20 at Canaccord
STAAR Surgical Non-GAAP EPS of -$0.30 beats by $0.26, revenue of $44.3M beats by $3.38M
Staar Surgical Co (STAA) Q2 2025 Earnings: EPS Loss of $(0.34) Beats Estimate, Revenue of $44. ...
Earnings Scheduled For August 6, 2025
Staar Surgical reports Q2 EPS (34c), consensus (56c)